Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery.

Abstract

INTRODUCTION:

Cataracts and diabetes are widespread pathologies that are of growing concern to the global population. In diabetic patients who have had cataract surgery, the worsening of preexisting diabetic macular edema or occurrence of pseudophakic cystoid macular edema are common causes of visual impairment even with the most advanced surgical techniques available today for phacoemulsification.

AREAS COVERED:

In this review, the authors assess the available literature to evaluate and compare different drugs, with the aim of establishing the best pharmacological strategies for the prevention and treatment of macular edema in diabetic patients undergoing cataract surgery.

EXPERT OPINION:

Guidelines for the optimal management of diabetic macular edema in conjunction with cataract surgery or treatment of pseudophakic cystoid macular edema in diabetic patients are still lacking. To treat these conditions, clinicians need to understand the pharmacokinetics, posology, and efficacy of available drugs: topical non-steroidal anti-inflammatory drugs (NSAIDs), intravitreal anti-vascular endothelial growth factors (VEGFs), and both topical and intravitreal steroids. Diabetic patients undergoing cataract surgery should receive topical NSAIDs to prevent pseudophakic cystoid macular edema. Intravitreal anti-VEGFs and steroids, in association with cataract surgery, are indicated for patients with preexisting diabetic macular edema or those at high risk of macular edema after surgery.

• Authors: Valentina Sarao, Daniele Veritti, Erica Maurutto, Nicolò Rassu, Enrico Borrelli, Anat Loewenstein, Srinivas Sadda, Paolo Lanzetta
• Journal: Expert opinion on pharmacotherapy (Expert Opin Pharmacother) Vol. 19 Issue 14 Pg. 1551-1563 (10 2018) ISSN: 1744-7666 [Electronic] England
• PMID: 30185069 (Publication Type: Journal Article, Review)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Steroids
• Bevacizumab

Topics

• Anti-Inflammatory Agents, Non-Steroidal (pharmacokinetics, therapeutic use)
• Bevacizumab (pharmacokinetics, therapeutic use)
• Cataract Extraction (adverse effects)
• Humans
• Hyperglycemia (diagnosis, etiology, metabolism)
• Macular Edema (complications, diagnosis, drug therapy, pathology)
• Phacoemulsification
• Steroids (therapeutic use)